What ASCO 2026’s “Translation” Theme Actually Means When You’re Running a Phase I Oncology Trial

Read article

“Context of vulnerability” and its role in targeted drug development

Renowned cancer researcher Dr. Daniel Von Hoff and…
Read Article

The “Lost Opportunity” in Phase I Oncology Trials

Cancer drug developers traditionally use the phase I…
Read Article

Dr. Dan Von Hoff honored at Governor’s Celebration

Our colleague Dan Von Hoff, M.D., a founder…
Read Article

Personalized Genomics: The First Report of a Cancer Genome

As reported by the New York Times last…
Read Article

Excellent cancer discussion on the Diane Rehm show

Yesterday morning’s Diane Rehm Show on NPR featured…
Read Article

Discover clinical trial management, biotech and pharma resources on document-sharing web sites

We’ve recently begun using two web sites that…
Read Article

Medelis expands CRO services into Europe, appoints Dr. Deirdre Tessman to run the operation

We’re very pleased to announce that our colleague…
Read Article

Meet us at BioPartnering Europe

We’re gearing up to attend the BioPartnering Europe…
Read Article

Using YouTube to recruit for clinical trials

Mark Senak, author of the informative Eye on…
Read Article